Search Results

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research Premium Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

details the construction of an open-access GPCR-lipid raft database and reviews key findings from his research research, this discussion will resonate. When integrating computational predictions with real-world pharmacological readouts If you see the research Sedaghat has accumulated over two decades of teaching and research in pharmacology, contributing as a His current efforts bridge teaching in Toronto and ongoing research, including the development of an

. 🤝 Webinar in collaboration with: Celtarys Research Fluorescent Probes for GLP-1R and GIPR Imaging: Johannes Broichhagen Group Leader Leibniz Research Institute for Molecular Pharmacology (FMP), Berlin Since 2020, he leads an independent research group at the FMP Berlin. His work carries direct translational relevance to diabetes and obesity therapeutics. research, and therapeutic development.

Our work helps biotech startups, research organizations, and CROs design operating systems that enable GPCR, we help organizations: ✅ Clarify vision and direction ✅ Translate research milestones into measurable

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Collaborative Research and Translational Approach Arthur and Yamina from Monash University discussed GPCR researchers in Australia and the initiation of a successful series of conferences. approach to research and its capacity to translate research into therapeutic commercialization. Translating Discovery Into Clinical Application Arthur and Yamina discussed the importance of translating

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Collaborative Research and Translational Approach Arthur and Yamina from Monash University discussed GPCR researchers in Australia and the initiation of a successful series of conferences. approach to research and its capacity to translate research into therapeutic commercialization. Translating Discovery Into Clinical Application Arthur and Yamina discussed the importance of translating

Martin Marro, currently Executive Director and Head of Cell Pharmacology at Eli Lilly’s Obesity Research career spans big pharma and biotech, encompassing functional assay development, GPCR internalization research For a deeper dive into modern GPCR research and tools, explore more episodes of the GPCR Podcast and This episode is relevant to anyone navigating the complex landscape of GPCR research and translational Researchers refining strategies for high-throughput screening or exploring biased signaling.

<< Back to podcast list Strategic Partner(s) Translating computational approaches to GPCR biologists Now in a tenure-track position, his research spans the development of computational methods such as structure-based Ricardo Capelli on the web Google Scholar ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter Premium Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Raimond Heukers , developed a nanobody platform within the research group and used this platform to develop During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research

Date & Time Friday, November 3rd / 8:30 AM Abstract Coming Soon About Mario Tiberi "I did my graduate research My addiction for dopamine led me to the Ottawa Hospital Research Institute (then the Moses and Rose Loeb Research Institute) to develop my independent research program. We are also currently developing the translational component of our research to capitalize on the druggability We hope our research will aid in the development of new therapeutic interventions for the alleviation

Deep-dive sessions focused on real pharmacology, real drug discovery challenges, and real translational A free, ongoing series bringing together researchers across academia and industry to share knowledge, Direct Access Live Q&A with leading GPCR researchers. scientists • Biotech and pharmaceutical researchers • Postdoctoral fellows and graduate researchers For researchers working in biotech, pharma, or academia, this type of continuing education can strengthen

Each session explores mechanistic models, translational challenges, and real-world therapeutic implications : • GPCR pharmacologists • Medicinal chemists working on receptor targets • Structural biologists • Translational scientists • Biotech and pharmaceutical researchers • Postdoctoral fellows and graduate researchers These GPCR webinars focus on conceptual frameworks, models, and translational insight that apply across For researchers working in biotech, pharma, or academia, this type of continuing education can strengthen

Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation Now at the University of Glasgow, his primary research interests are focused on the rational design of In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma research.

iPSC-derived cellular models and biosensor approaches for studying GPCR signaling and improving translational Yet despite advances in screening technologies, the translation of these discoveries into clinical success His research has focused extensively on GPCR oligomerization, signaling complex assembly, and biased This research examines signaling architecture both at the cell surface and within the nucleus, providing

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and His main research group centers on the function, structure, and regulation of G protein-coupled receptors His experience also includes translating knowledge generated into the selection of targets, screening Milligan has published more than 550 peer-reviewed articles and his research has been cited more than Premium Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

Insights for GPCR researchers and functional assay innovators. << Back to podcast list Strategic Partner Laura Duvall, whose research tracks the molecular mechanisms that govern mosquito behavior, focusing This episode is essential for anyone advancing GPCR-targeted research in physiological or behavioral As a postdoctoral researcher in Leslie Vosshall’s laboratory at Rockefeller University, Dr. and translational science.

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through Our Vision A world where GPCR insights translate quickly into real‑world therapies through an open, trusted What We Do (in Three Verbs) Connect — Researchers, founders, students, and industry partners meet, learn Join To join the community, you should be actively related to the GPCR field , including: Academic researchers Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

Industry Collaboration How do GPCR tools move from individual academic labs into broad use across the research Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen Listeners will walk away with a clearer view of how academic innovation translates into tools for high-throughput at the CIQUS Research Center in Spain. By integrating advanced tools and translational biology, his work directly informs therapeutic strategies

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute of Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched Gainetdinov was included in the Web of Science (WOS) Highly Cited Researchers (HCR) list, representing

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology GPCR research into novel therapies for patients. " Irfan Dhanidina on the web LinkedIn The Org DIBIZ Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate Slosky’s work has been recognized through several travel and research awards, including the William James In addition to research, Dr.

Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this Maria Majellaro, CSO of Celtarys Research, shares the story behind the company’s journey from academic GPCR and Celtarys, built on a shared commitment to empowering the GPCR research community. Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge Jhonny Azuaje they laid the groundwork for the future creation of Celtarys Research.

Why This Matters Translating basic GPCR science into actual medicines is broken. Learn in This Episode How Ajay’s failed MD/PhD application rerouted his path toward a breakthrough GPCR research Who Should Listen PhD students and postdocs exploring biotech careers GPCR scientists interested in translational Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine. Premium Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016 ) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both postdoc Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular Premium Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

Alex Serafini shares why pain research must start with real-world behavior and models before drilling by personal experience and a desire to innovate in pain management, Alex pursued a master's in pain research “I started going through what I was going through… and that got me very interested in research.” — Alex He points out that GPCRs—especially orphan and CNS-associated ones—are often downplayed in pain research That changed everything.” — Alex Serafini Pivoting: Redefining the Pain Research Playbook Looking ahead

About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the CHUM Research Centre. recognized for having identified the adenosine-producing enzyme CD73 as a new cancer target, and for his translational Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital Research

questions of how Adhesion GPCRs integrate the different signals on a molecular level and how these are translated Simone Prömel on the web Prömel Lab Pubmed Researchgate Twitter Dr. GPCR Ecosystem About Dr. Ines Liebscher on the web Website LinkedIn Researchgate Dr. Premium Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers